No AccessJournal of UrologyInvestigative Urology1 Dec 1998EXPRESSION OF TGF-beta-1 mRNA AND ULTRASTRUCTURAL ALTERATIONS IN PHARMACOLOGICALLY INDUCED PROLONGED PENILE ERECTION IN A CANINE MODEL MAQSOOD UL-HASAN, AHMED EL-SAKKA, I. CELESTE LEE, TIEN-SZE YEN, B. RAJVIR DAHIYA, and TOM LUEF. MAQSOOD UL-HASANMAQSOOD UL-HASAN , AHMED EL-SAKKAAHMED EL-SAKKA , CELESTE LEECELESTE LEE , TIEN-SZE YENTIEN-SZE YEN , RAJVIR DAHIYARAJVIR DAHIYA , and TOM LUETOM LUE View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)62307-3AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: Transforming growth factor beta (TGF-beta) is known to induce fibrosis. Our objective was to study the role of TGF-beta as a possible mediator of fibrosis that may follow prolonged penile erection. Materials and Methods: Prolonged penile erection was induced in seven adult male mongrel dogs by intracavernosal injection of papaverine into one of the corpora cavernosa while the other was used as a control. Intracavernosal pressure measurements were carried out prior to administration of papaverine and at the end of the procedure. Penile tissue was collected from anesthetized animals prior to euthanasia for histological and electron microscopic (EM) studies. RT-PCR was carried out for detection of mRNA on same tissue samples. Results: The light microscopy showed stasis of blood in the cavernosal sinusoids. EM studies revealed sporadic endothelial defects, loss of plasma membrane integrity and cytoplasmic condensation. There was expression of TGF-beta 1 mRNA in 66.7% of the experimental group compared with 16.7% of the control group. Conclusions: Pharmacologically induced low flow prolonged penile erection in canine models is associated with histomorphological changes in relatively short periods of time, suggesting that early therapeutic intervention is desirable. The gene expression for TGF-beta 1 may be a mediator of fibrosis; therefore the use of anti-TGF-beta agents presents a possible tool for therapeutic intervention. References 1 : Urological complications of sickle cell disease in a pediatric population. J. Urol.1987; 138: 592. Link, Google Scholar 2 : Pathophysiology of prolonged penile erection is associated with trazodone use. J. Urol.1991; 145: 601. Google Scholar 3 : Association of priapism in phenothiazine therapy. J. Urol.1976; 116: 51. Link, Google Scholar 4 : Priapism as probable sequela to medication. Scand. J. Nephrol.1968; 2: 81. Google Scholar 5 : Management of Impotence and Infertility. Edited by . Philadelphia: J. P. Lippincott1994: 122. ch. 10. Google Scholar 6 : Traumatic laceration of intracavernosal arteries: the pathophysiology of nonischemic, high flow priapism. J. Urol.1990; 143: 129. Link, Google Scholar 7 : Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N. Engl. J. Med.1996; 334: 873. Google Scholar 8 : Priapism: a refined approach to diagnosis and treatment. J. Urol.1986; 136: 104. Link, Google Scholar 9 : Priapism, reasons for failure of therapy. J. Urol.1960; 83: 420. Link, Google Scholar 10 : New approach to hot-start polymerase chain reaction using Taq DNA polymerase antibody. Urol. Oncol.1995; 1: 42. Google Scholar 11 : Differential gene expression of TGF alpha, beta, EGF, KGF, and their receptors in fetal and adult human prostate tissues and cancer cell lines. Urology1996; 48: 963. Google Scholar 12 : DNA repair genes in human fetal and adult prostate tissues and cancer cell lines using differential RT-PCR. Urol. Oncol.1996; 2: 52. Google Scholar 13 : The ultrastructure of the erectile tissue in priapism. J. Urol.1986; 135: 142. Link, Google Scholar 14 : Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells. Nature1976; 264: 26. Google Scholar 15 : Growth factors from murine sarcoma virus-transformed cells. Proc. Natl. Acad, Sci. USA1978; 75: 4001. Google Scholar 16 : Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factor. Proc. Natl. Acad. Sci. USA1983; 80: 6264. Google Scholar 17 : Further study of TGF betas released by virally transformed and non-transformed cells. Int. J. Cancer1985; 35: 553. Google Scholar 18 : Purification and initial characterization of a type beta transforming growth factor from human placenta. Proc. Natl. Acad. Sci. USA1983; 80: 3676. Google Scholar 19 : Purification and properties of a type beta transforming growth factor from bovine kidney. Biochemistry1983; 22: 5692. Google Scholar 20 : Transforming growth factor beta in human platelets: identification of major site, purification and characterization. J. Biol. Chem.1987; 33: 95. Google Scholar 21 : Transforming growth factors and control of neoplastic growth. J. Cell. Biochem.1987; 33: 95. Google Scholar 22 : The transforming growth factor-beta family. Ann. Rev. Cell. Biol.1990; 6: 597. Google Scholar 23 : The TGF-beta family of growth and differentiating factors. Cell1987; 49: 437. Google Scholar 24 : Evolutionary origin of transforming growth factor beta family. DNA Cell. Biol.1992; 11: 497. Google Scholar 25 : Complementary deoxyribonucleic acid cloning of a messenger ribonucleic acid encoding transforming growth factor beta-4 from chick embryo chondrocyte. Mol. Endocrinol.1988; 2: 1186. Google Scholar 26 : Transforming growth factor beta biological function and chemical structure. Science1986; 233: 532. Google Scholar 27 : Transforming growth factor beta gene maps to human chromosome 19 long arm and to mouse chromosome 7. Somatic Cell. Mol. Genet.1986; 12: 281. Google Scholar 28 : Transforming growth factor type beta regulation of actin mRNA. J. Cell. Physiol.1986; 127: 83. Google Scholar 29 : Transforming growth factor beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem.1986; 261: 4337. Google Scholar 30 : Transforming growth factor beta increase mRNA for matrix proteins in the presence and the absence of mRNA stability. Proc. Natl. Acad. Sci. USA1988; 85: 1105. Google Scholar 31 : Cell adhesion protein receptors as target for transforming growth factor beta action. Cell1987; 51: 189. Google Scholar 32 : Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. J. Eur. Mol. Biol. Organ.1987; 6: 1899. Google Scholar 33 : Transforming growth factor beta induction of type 1 plasminogen activator inhibitor. J. Biol. Chem.1987; 262: 17467. Google Scholar 34 Transforming growth factor beta 1 exhibits delayed gene expression following focal cerebral ischemia. Brain Res. Bull.1995; 36: 607. Google Scholar 35 : Expression of transforming growth factor beta 1 and interleukin 1 mRNA in rat brain following transient forebrain ischemia. Acta Neuropathol.1993; 86: 439. Google Scholar 36 : Increased expression of transforming growth factor beta 1 in brain tissue after ischemic stroke. Stroke1996; 27: 852. Google Scholar 37 : Elevated expression of transforming growth factor beta and proteoglycan production in experimental glomerulonephritis. J. Clin. Invest.1990; 86: 453. Google Scholar 38 : Qualitative and quantitative studies of antibody induced mesangial cell damage in the rat. Kidney Int.1987; 32: 514. Google Scholar 39 : Sustained expression of TGF beta 1 underlies development of progressive kidney fibrosis. Kidney Int.1994; 45: 916. Google Scholar 40 : Increased transforming growth factor beta 1 expression in human liver disease. J. Hepatol.1992; 14: 259. Google Scholar 41 : Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc. Natl. Acad. Sci. USA1991; 88: 6642. Google Scholar 42 : Increased production and immunohistochemical localization of transforming growth factor beta 1 in idiopathic pulmonary fibrosis. Am. J. Respir. Cell. Mol. Biol.1991; 5: 155. Google Scholar 43 : Peyronie's disease is associated with an increase in transforming growth factor beta protein expression. J. Urol. (Suppl.)1997; 157: 361. Google Scholar 44 : Relationship between cavernosal ischemia and corporal veno-occlusive dysfunction in an animal model. J. Urol.1997; 157: 1011. Link, Google Scholar 45 : Ischemia induced alteration in cavernosal eicosanoids and TGF-beta 1 impairs nitric oxide pathway and relaxation of cavernosal tissue. Int. J. Impotence Res.1996; 8: 107. Google Scholar 46 : Transforming growth factor beta in diseases: the dark side of tissue repair. J. Clin. Invest.1992; 90: 1. Google Scholar 47 : Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature (Lond.)1990; 346: 371. Google Scholar 48 : Control of scaring in adult wounds by neutralizing antibody to transforming growth factor beta. Lancet1992; 339: 213. Google Scholar 49 : Effects of transforming growth factor beta 1 on scar production in the central nervous system of the rat. Eur. J. Neurosci.1994; 6: 355. Google Scholar 50 : Natural inhibitor of transforming growth factor beta protects against scarring in experimental kidney disease. Nature1992; 360: 361. Google Scholar From the Department of Urology, University of California, San Francisco, CA 94143-0738© 1998 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited byBURNETT A (2018) Pathophysiology of Priapism: Dysregulatory Erection Physiology Thesis.Journal of Urology, VOL. 170, NO. 1, (26-34), Online publication date: 1-Jul-2003. Volume 160Issue 6 Part 1December 1998Page: 2263-2266 Advertisement Copyright & Permissions© 1998 by American Urological Association, Inc.MetricsAuthor Information MAQSOOD UL-HASAN More articles by this author AHMED EL-SAKKA More articles by this author CELESTE LEE More articles by this author TIEN-SZE YEN More articles by this author RAJVIR DAHIYA More articles by this author TOM LUE More articles by this author Expand All Advertisement PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
UL-HASAN et al. (1998) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: